Search

everythinglearnresearchcommunity

for

Search:↓

New treatments focusing on immune pathways show promise for stubborn hair loss.

Baricitinib helped some patients with tough-to-treat hair loss regrow hair, but more research is needed on its safety.

Dupilumab improved severe atopic dermatitis in a patient who didn't respond to other treatments.

Ringworm around the eyes often gets misdiagnosed, leading to eyelash loss, but antifungal treatment can improve the condition.

New treatments for severe hair loss often fail, but some patients see hair regrowth with specific therapies, and treatment should be tailored to the individual's situation.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

No systemic treatment for alopecia areata has strong evidence of effectiveness.

Acne in children varies by age and severity, requires a pediatric treatment approach, and may need diagnostic evaluation for underlying conditions.

Alopecia Areata is treated with drugs and therapies to reduce inflammation and immune response.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

The Brazilian Society of Dermatology agrees that oral isotretinoin is effective for acne and other skin conditions, and it's safe when monitored, but more research is needed on dosing and duration.

Methotrexate reduced the need for steroids in asthma patients without worsening their condition.

Mycophenolate mofetil can effectively treat autoimmune hepatitis when standard drugs fail.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

The document concludes that inhalation of oxygen and sumatriptan injections are primary for cluster headaches, indomethacin for paroxysmal hemicrania, and lidocaine and lamotrigine for SUNCT, but SUNCT often resists treatment.

Simvastatin/ezetimibe did not effectively treat severe alopecia areata and caused side effects in some patients.

Hormonal therapies are safe and effective for treating acne in female adolescents, with specific treatments for those with endocrine disorders.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Traditional treatment for pediatric alopecia areata is most effective and should be first choice.

Monochromatic light devices, especially the 308-nm excimer laser, are promising for treating alopecia areata but more research is needed.

Doxycycline can effectively treat hair loss caused by EGFR inhibitors.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

Some drugs may help treat both COVID-19 and radiation injury.

Childhood Alopecia Areata causes hair loss and requires varied treatments, with psychological support being crucial.

Methotrexate effectively controls eye inflammation in Japanese patients with non-infectious uveitis but requires careful monitoring for side effects.

Platelet-rich plasma shows potential for hair loss and skin rejuvenation but needs more research for widespread use.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

Managing frontal fibrosing alopecia and lichen planus pigmentosus is challenging due to resistant hair loss and skin discoloration.